← Back to Search

Behavioural Intervention

CRM Intervention for Geriatric Drug Safety

N/A

Waitlist Available

Led By Gurdev Singh, MScEng. PhD.

Research Sponsored by Agency for Healthcare Research and Quality (AHRQ)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients for chart review must have cardiovascular disease

Patients for chart review must be aged over 64

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial will test whether a CRM intervention can reduce medication errors in older adults in primary care settings.

Who is the study for?

This trial is for individuals over the age of 64 with cardiovascular disease who have visited a practice within the Western New York Practice-Based Research Network in the past year. The practice must be in an area with a shortage of health professionals.Check my eligibility

What is being tested?

The study is testing if a CRM intervention, which has been successful in aviation and some medical settings, can reduce medication errors among older adults in primary care environments.See study design

What are the potential side effects?

Since this trial focuses on improving drug safety through process changes rather than testing new medications, it does not directly involve side effects from interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with a heart condition.

Select...

I am 65 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in culture of safety

Change in number of total and preventable ADEs.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)Lead Sponsor

399 Previous Clinical Trials

6,817,548 Total Patients Enrolled

Gurdev Singh, MScEng. PhD.Principal InvestigatorState University of New York at Buffalo

Media Library

CRM Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT00277173 — N/A

Cardiovascular Disease Research Study Groups:

Cardiovascular Disease Clinical Trial 2023: CRM Intervention Highlights & Side Effects. Trial Name: NCT00277173 — N/A

CRM Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00277173 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I become a part of this research project?

"Eligible patients must be aged 65 or above, have cardiovascular diseases, and the medical practice they visit must be located in a Health Professional Shortage Area or Physician Scarcity Area. Additionally, the Practice must be a member of the Western New york Practice-Based Research Network."

Answered by AI

Are there any remaining spots available in this trial for new patients?

"Unfortunately, this particular trial is not looking for any more participants at the moment according to the most recent information found on clinicaltrials.gov. This study was originally posted on January 1st 2006 but has not been updated in over a decade. However, there are 436 other trials that patients might be interested in which are currently recruiting individuals."

Answered by AI